Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant …
N Han, H Yun, J Hong, IW Kim, E Ji, SH Hong… - European journal of …, 2013 - Springer
Purpose Tacrolimus is a commonly used immunosuppressant in solid organ transplantation
recipients, but it is characterized by a narrow therapeutic range and large inter-individual …
recipients, but it is characterized by a narrow therapeutic range and large inter-individual …
Population pharmacokinetic–pharmacogenetic model of tacrolimus in the early period after kidney transplantation
N Han, S Ha, H Yun, MG Kim, SI Min… - Basic & clinical …, 2014 - Wiley Online Library
As tacrolimus has a rather narrow therapeutic range and high individual variability in its
pharmacokinetics, it is important to determine the cause of the variation in tacrolimus …
pharmacokinetics, it is important to determine the cause of the variation in tacrolimus …
Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis
Control of multi-drug-resistant tuberculosis (MDR-TB) requires extensive, supervised
chemotherapy because second-line anti-TB drugs have a narrower therapeutic range than first-line …
chemotherapy because second-line anti-TB drugs have a narrower therapeutic range than first-line …
Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients
…, JI Lee, HD Choi, J Kim, JS Park, YJ Cho, HI Yoon… - Tuberculosis, 2015 - Elsevier
Diabetes mellitus (DM) is a well-known risk factor to develop tuberculosis (TB). Some reports
indicate the serum concentrations of anti-TB drugs are lower in patients with TB and DM …
indicate the serum concentrations of anti-TB drugs are lower in patients with TB and DM …
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients
JJ Mao, Z Jiao, HY Yun, CY Zhao… - British journal of …, 2018 - Wiley Online Library
Aims Several population pharmacokinetic (popPK) models for ciclosporin (CsA) in adult renal
transplant recipients have been constructed to optimize the therapeutic regimen of CsA. …
transplant recipients have been constructed to optimize the therapeutic regimen of CsA. …
[HTML][HTML] Fine-tuning of BERT model to accurately predict drug–target interactions
The identification of optimal drug candidates is very important in drug discovery. Researchers
in biology and computational sciences have sought to use machine learning (ML) to …
in biology and computational sciences have sought to use machine learning (ML) to …
[HTML][HTML] Increased exposure of tacrolimus by co-administered mycophenolate mofetil: population pharmacokinetic analysis in healthy volunteers
JH Kim, N Han, MG Kim, HY Yun, S Lee, E Bae… - Scientific Reports, 2018 - nature.com
The objective of the study was to investigate the pharmacokinetic drug-drug interactions
between tacrolimus (TAC) and mycophenolate mofetil (MMF) in healthy Korean male volunteers…
between tacrolimus (TAC) and mycophenolate mofetil (MMF) in healthy Korean male volunteers…
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays
In this study, Caco-2 permeability results from different laboratories were compared. Six
different sets of apparent permeability coefficient (P app ) values reported in the literature were …
different sets of apparent permeability coefficient (P app ) values reported in the literature were …
Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of …
…, S Jung, JY Lee, JH Lee, H Yun… - CPT …, 2022 - Wiley Online Library
… Lien Thi Ngo, Sung-yoon Yang and Sooyoung Shin contributed equally to this work as the
first-authors. Jong-Hwa Lee, Hwi-yeol Yun and Jung-woo Chae contributed equally to this …
first-authors. Jong-Hwa Lee, Hwi-yeol Yun and Jung-woo Chae contributed equally to this …
Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients
N Han, H Yun, IW Kim, YJ Oh, YS Kim… - European journal of clinical …, 2014 - Springer
Purpose Enteric-coated mycophenolate sodium (EC-MPS) is effective and safe in
preventing rejection after transplantation and is mainly transported by ABCs and OATPs and …
preventing rejection after transplantation and is mainly transported by ABCs and OATPs and …